PL EN


Preferences help
enabled [disable] Abstract
Number of results
2007 | 79 | 2 | 129-133
Article title

Somatostatinoma of the Pancreas; Difficulties in Preoperative Diagnostic Approaches - A Case Report

Content
Title variants
Languages of publication
EN
Abstracts
EN
Somatostatinoma is the rarest neuroendocrine tumor of the digestive tract. About 60% of somatostatinomas arise in the pancreas. This study presents a case of a 51-year-old male patient with tumor of the pancreas. Despite wide preoperative diagnostic examinations, it was impossible to determine the histological type of the tumor preoperatively. The patient was qualified for surgical procedure, during which the tumor was enucleated. The tumor was classified as somatostatinoma through immunohistochemical examination. The postoperative course was complicated by a small fluid collection, which arose in area of enucleation; the cistern was absorbed spontaneously. Currently, the patient is under surgical ambulatory care and is in general, in good condition.
Publisher
Year
Volume
79
Issue
2
Pages
129-133
Physical description
Dates
published
1 - 2 - 2007
online
24 - 9 - 2007
References
  • Harris GJ, Tio F, Cruz AB Jr: Somatostatinoma: a case report and review of the literature. J Surg Oncol 1987; 36: 8-16.[Crossref]
  • Bolanowski M, Kos-Kudła B: Etiologia, występowanie, podział kliniczny i objawy guzów GEP. Onkologia po Dyplomie. Wydanie specjalne. 2005; 7-10.
  • Azimuddin K, Chamberlain RS: The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001; 81: 511-25.[Crossref][PubMed][WoS]
  • House MG, Yeo CJ, Schulick RD: Periampullary pancreatic somatostatinoma. Ann Surg Oncol 2002; 9: 869-74.[Crossref][PubMed]
  • Vinik AL, Strodel WE, Eckhauser FE et al.: Somatostatinomas, Pomas, neurotensinomas. Semin Oncol 1987; 14: 263-81.
  • Franek E: Hormonalnie czynne neuroendokrynne guzy trzustki. Przegl Gastroenterol 2006; 1: 22-28.
  • Soga J, Yakuwa Y: Somatostatinoma inhibitory syndrome:a statistical evaluation of 173 reported cases as compared to other pancreatic endocrino-mas. J Exp Clin Cancer Res 1999; 18: 13-22.
  • Mullan MH, Gauger PG, Thompson NW: Endocrine tumors of the pancreas: review and recent advances. ANZ J Surg 2001; 71: 475-82.[PubMed][Crossref]
  • Kaltsas GA, Besser GM, Grossman AB: Diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004; 25: 458-511.[Crossref][PubMed]
  • Anderson MA, Carpenter S, Thompson NW et al.: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of pancreas. Am J Gastroenterol 2000; 95: 2271-77.[Crossref]
  • Tjon A, Tham RT, Jansen JB et al.: Imaging features of somatostatinoma: MR, CT, US and angiography. J Comput Assist Tomogr 1994; 18: 427-31.
  • Semelka RC, Custodio CM, Cem Balci M et al.: Neuroendocrine tumors of pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 2000; 11: 141-48.[Crossref]
  • Marakis G, Ballas K, Rafailidis S et al.: Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis - a case report. Pancreatology 2005; 5: 295-99.[Crossref]
  • Becherer A, Szabo M, Karanikas G et al.: Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 2004; 45: 1161-67.
  • Norton JA, Cromack DT, Shawker TH: Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 1988; 207: 160-68.[PubMed][Crossref]
  • Ramage JK, Davies AHG, Ardill J et al.: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54: 1-16.[WoS]
  • Plöckinger U, Wiedenmann B: Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours. Neuroendocrinology 2004; 80: 35-38.[Crossref][PubMed]
  • Brentjens R, Saltz L: Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001; 81: 527-542.[Crossref]
  • Cichocki A: Chirurgiczne leczenie guzów neuroendokrynnych przewodu pokarmowego. Onkologia po Dyplomie. Wydanie specjalne. 2005; 42-46.
  • Madeira I, Terris B, Voss M et al.: Prognostic factor in patients with endocrine tumors of the duodenopancreatic area. Gut 1998; 43: 422-27.[Crossref]
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_v10035-007-0021-y
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.